Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

9.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.3K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

715
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
715
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

1.2K
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
1.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

557
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
557
Cancer Survival Analysis01:21

Cancer Survival Analysis

838
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

490
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
490

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An approach to nonparametric inference on the causal dose-response function.

Journal of causal inference·2026
Same author

Sequential invitations to FOBT screening and colorectal cancer incidence.

Scientific reports·2026
Same author

"Within-Trial" Prognostic Score Adjustment Is Targeted Maximum Likelihood Estimation.

Pharmaceutical statistics·2026
Same author

Machine learning to optimize precision in the analysis of randomized trials: A journey in pre-specified, yet data-adaptive learning.

Clinical trials (London, England)·2026
Same author

Discovery of critical thresholds in mixed exposures and estimation of policy intervention effects.

Journal of causal inference·2026
Same author

Bridging binarization: causal inference with dichotomized continuous exposures.

Journal of causal inference·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
Same journal

Subgroup Analysis of Interval-censored Failure Time Data With Application to Alzheimer's Disease.

Statistics in medicine·2026
Same journal

Rejoinder to Commentaries on "A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events".

Statistics in medicine·2026
Same journal

A Multi-Stage Drop-the-Loser Design With Superiority Boundaries.

Statistics in medicine·2026
Same journal

Interpretable ROI Identification in Brain Image Analysis: Overcoming CNN Black Box Challenges With Kriging-Enhanced Adaptive Sampling.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Apr 9, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

Powering RCTs for Marginal Effects With GLMs Using Prognostic Score Adjustment.

Emilie Højbjerre-Frandsen1,2, Mark J van der Laan3, Alejandro Schuler3

  • 1Biostatistics Methods, Novo Nordisk A/S, Søborg, Denmark.

Statistics in Medicine
|April 8, 2026
PubMed
Summary
This summary is machine-generated.

This study enhances randomized clinical trials (RCTs) by using historical data to improve statistical power and treatment effect estimation. The new method boosts efficiency without bias, aiding drug development and clinical research.

Keywords:
causal inferencegeneralized linear modelshistorical dataprognostic scorerandomized trialsstatistical efficiency

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K

Related Experiment Videos

Last Updated: Apr 9, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Statistical Power Analysis

Background:

  • Accurate estimation of marginal treatment effects in randomized clinical trials (RCTs) is vital for intervention efficacy.
  • Enhancing statistical power in RCTs is a key objective, with historical data offering potential efficiency gains.
  • Existing methods for historical data borrowing often compromise type I error rate control.

Purpose of the Study:

  • To extend prognostic score adjustment methodology to generalized linear models (GLMs) for plug-in analysis in RCTs.
  • To enhance the efficiency and precision of marginal treatment effect estimates in RCTs by leveraging historical control data.
  • To introduce a method that improves statistical power without introducing bias, building upon prior work.

Main Methods:

  • Training a prognostic model on historical control data.
  • Incorporating prognostic scores as covariates in a plug-in GLM analysis of trial data.
  • Extending the GLM plug-in method to include Negative Binomial regression and providing a variance estimation formula.

Main Results:

  • The proposed method achieves local semi-parametric efficiency under an additive treatment effect assumption.
  • Demonstrated increased statistical power or reduced standard error, even without an additive treatment effect.
  • Showcased reductions in estimated variance using clinical trial data, confirming theoretical benefits.

Conclusions:

  • The enhanced GLM plug-in method effectively utilizes historical data to improve RCT efficiency and precision.
  • This approach offers a statistically sound way to increase power in clinical trials without compromising bias control.
  • The findings have implications for optimizing trial design and analysis, particularly in pharmaceutical research.